Analysis of In Vitro Aptamer Selection Parameters

Journal of Molecular Evolution

Volumn 81, Issue 5-6, 2015, Pages 150-161

  McKeague, Maureen ^a   McConnell, Erin M ^a   Cruz Toledo, Jose ^a   Bernard, Elyse D ^b   Pach, Amanda ^a   Mastronardi, Emily ^a   Zhang, Xueru ^a   Beking, Michael ^a   Francis, Tariq ^a   Giamberardino, Amanda ^a   Cabecinha, Ashley ^a   Ruscito, Annamaria ^a   Aranda Rodriguez, Rocio ^b   Dumontier, Michel ^a,c   DeRosa, Maria C ^a  

^a CARLETON UNIVERSITY   (Canada)

^b HEALTH CANADA   (Canada)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aptamer; Aptamer target; Database; In vitro selection; SELEX

Indexed keywords

APTAMER;

PROCEDURES; SYSTEMATIC EVOLUTION OF LIGANDS BY EXPONENTIAL ENRICHMENT APTAMER TECHNIQUE;

APTAMERS, NUCLEOTIDE; SELEX APTAMER TECHNIQUE;

EID: 84948383751     PISSN: 00222844     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00239-015-9708-6     Document Type: Article

References (57)

1. Alam KK, Chang JL, Burke DH (2015) FASTAptamer: a bioinformatic toolkit for high-throughput sequence analysis of combinatorial selections. Mol Ther Nucleic acids 4:e230. doi:10.1038/mtna.2015.4
2. Apweiler R, Bairoch A, Wu CH (2004) Protein sequence databases. Curr Opin Chem Biol 8:76–80. doi:10.1016/j.cbpa.2003.12.004
3. Baird GS (2010) Where are all the aptamers? Am J Clin Pathol 134:529–531. doi:10.1309/AJCPFU4CG2WGJJKS
4. Barrick JE, Breaker RR (2007) The distributions, mechanisms, and structures of metabolite-binding riboswitches. Genome Biol 8:R239. doi:10.1186/gb-2007-8-11-r239
5. Berezovski M, Musheev M, Drabovich A, Krylov SN (2006) Non-SELEX selection of aptamers. J Am Chem Soc 128:1410–1411. doi:10.1021/ja056943j
6. Bordeaux J et al (2010) Antibody validation. Biotechniques 48:197–209. doi:10.2144/000113382
7. Carothers JM, Oestreich SC, Szostak JW (2006) Aptamers selected for higher-affinity binding are not more specific for the target ligand. J Am Chem Soc 128:7929–7937. doi:10.1021/ja060952q
8. Carothers JM, Goler JA, Kapoor Y, Lara L, Keasling JD (2010) Selecting RNA aptamers for synthetic biology: investigating magnesium dependence and predicting binding affinity. Nucleic Acids Res 38:2736–2747. doi:10.1093/nar/gkq082
9. Carter CW Jr, Yin Y (1994) Quantitative analysis in the characterization and optimization of protein crystal growth. Acta Crystallogr Sect D 50:572–590. doi:10.1107/S0907444994001228
10. Catherine AT, Shishido SN, Robbins-Welty GA, Diegelman-Parente A (2014) Rational design of a structure-switching DNA aptamer for potassium ions. FEBS Open Bio 4:788–795. doi:10.1016/j.fob.2014.08.008
11. Cho EJ, Lee JW, Ellington AD (2009) Applications of aptamers as sensors. Annu Rev Anal Chem (Palo Alto, Calif) 2:241–264. doi:10.1146/annurev.anchem.1.031207.112851
12. Ciesiolka J, Illangasekare M, Majerfeld I, Nickles T, Welch M, Yarus M, Zinnen S (1996) Affinity selection-amplification from randomized ribooligonucleotide pools. Methods Enzymol 267:315–335
13. Cruz-Toledo J et al (2012) Aptamer base: a collaborative knowledge base to describe aptamers and SELEX experiments. Database 2012:bas006. doi:10.1093/database/bas006
14. Deigan KE, Ferre-D’Amare AR (2011) Riboswitches: discovery of drugs that target bacterial gene-regulatory RNAs. Acc Chem Res 44:1329–1338. doi:10.1021/ar200039b
15. Deng Q, German I, Buchanan D, Kennedy RT (2001) Retention and separation of adenosine and analogues by affinity chromatography with an aptamer stationary phase. Anal Chem 73:5415–5421
16. Ellington AD, Szostak JW (1990) In vitro selection of RNA molecules that bind specific ligands. Nature 346:818–822. doi:10.1038/346818a0
17. Ellington AD, Szostak JW (1992) Selection in vitro of single-stranded DNA molecules that fold into specific ligand-binding structures. Nature 355:850–852. doi:10.1038/355850a0
18. Famulok M, Hartig JS, Mayer G (2007) Functional aptamers and aptazymes in biotechnology, diagnostics, and therapy. Chem Rev 107:3715–3743. doi:10.1021/cr0306743
19. Fusco D, Barnum TJ, Bruno AE, Luft JR, Snell EH, Mukherjee S, Charbonneau P (2014) Statistical analysis of crystallization database links protein physico-chemical features with crystallization mechanisms. PLoS One 9:e101123. doi:10.1371/journal.pone.0101123
20. Gilbert W (1986) Origin of life: the RNA world. Nature 319:618
21. Gold L et al (2010) Aptamer-based multiplexed proteomic technology for biomarker discovery. PloS one 5:e15004. doi:10.1371/journal.pone.0015004
22. Gold L, Janjic N, Jarvis T, Schneider D, Walker JJ, Wilcox SK, Zichi D (2012) Aptamers and the RNA world, past and present. Cold Spring Harb Perspect Biol. doi:10.1101/cshperspect.a003582
23. Hall B, Micheletti JM, Satya P, Ogle K, Pollard J, Ellington AD (2009) Design, synthesis, and amplification of DNA pools for in vitro selection. In: Ausubel FM et al (eds) Current protocols in molecular biology, Chapter 24, pp 24–22. doi:10.1002/0471142727.mb2402s88
24. Hianik T, Ostatna V, Sonlajtnerova M, Grman I (2007) Influence of ionic strength, pH and aptamer configuration for binding affinity to thrombin. Bioelectrochemistry 70:127–133. doi:10.1016/j.bioelechem.2006.03.012
25. Hoinka J, Berezhnoy A, Sauna ZE, Gilboa E, Przytycka TM (2014) AptaCluster—a method to cluster HT-SELEX aptamer pools and lessons from its application. Res Comput Mol Biol 8394:115–128. doi:10.1007/978-3-319-05269-4_9
26. Jagannathan V, Roulet E, Delorenzi M, Bucher P (2006) HTPSELEX–a database of high-throughput SELEX libraries for transcription factor binding sites. Nucleic Acids Res 34:D90–D94. doi:10.1093/nar/gkj049
27. Jayasena SD (1999) Aptamers: an emerging class of molecules that rival antibodies in diagnostics. Clin Chem 45:1628–1650
28. Jhaveri S, Ellington A (2002) In vitro selection of RNA aptamers to a small molecule target. In: Beaucage SL et al. (eds) Current protocols in nucleic acid chemistry, Chapter 9, pp 9–5. doi:10.1002/0471142700.nc0905s08
29. Lee JF, Hesselberth JR, Meyers LA, Ellington AD (2004) Aptamer database. Nucleic Acids Res 32:D95–D100. doi:10.1093/nar/gkh094
30. Legiewicz M, Lozupone C, Knight R, Yarus M (2005) Size, constant sequences, and optimal selection. RNA (New York, NY) 11:1701–1709. doi:10.1261/rna.2161305
31. Li Y, Geyer CR, Sen D (1996) Recognition of anionic porphyrins by DNA aptamers. Biochemistry 35:6911–6922. doi:10.1021/bi960038h
32. Lozupone C, Changayil S, Majerfeld I, Yarus M (2003) Selection of the simplest RNA that binds isoleucine. RNA (New York, NY) 9:1315–1322
33. Luo X et al (2010) Computational approaches toward the design of pools for the in vitro selection of complex aptamers. RNA (New York, NY) 16:2252–2262. doi:10.1261/rna.2102210
34. Mascini M, Palchetti I, Tombelli S (2012) Nucleic acid and peptide aptamers: fundamentals and bioanalytical aspects. Angew Chem (Int Edin English) 51:1316–1332. doi:10.1002/anie.201006630
35. Mattice CM, DeRosa MC (2015) Status and prospects of aptamers as drug components. BioDrugs 29:151–165. doi:10.1007/s40259-015-0126-5
36. McKeague M, DeRosa MC (2012) Challenges and opportunities for small molecule aptamer development. J Nucleic Acids 2012:748913. doi:10.1155/2012/748913
37. McKeague M, DeRosa MC (2014) Aptamers and SELEX: tools for the development of transformative molecular recognition technology. Aptamers Synth Antib 1:12–16
38. McKeague M, Giamberardino A, DeRosa MC (2011) Advances in aptamer-based biosensors for food safety. In: Environmental Biosensors. Vernon Somerset, InTech, SBN: 9789533074863, pp 17–18–42
39. McKeague M et al (2015) Comprehensive analytical comparison of strategies used for small molecule aptamer evaluation. Anal Chem. doi:10.1021/acs.analchem.5b02102
40. McPherson A, Cudney B (2014) Optimization of crystallization conditions for biological macromolecules. Acta Crystallogr Sect F 70:1445–1467. doi:10.1107/S2053230X14019670
41. Neves MA, Reinstein O, Saad M, Johnson PE (2010) Defining the secondary structural requirements of a cocaine-binding aptamer by a thermodynamic and mutation study. Biophys Chem 153:9–16. doi:10.1016/j.bpc.2010.09.009
42. Nimjee SM, Rusconi CP, Sullenger BA (2005) Aptamers: an emerging class of therapeutics. Annu Rev Med 56:555–583. doi:10.1146/annurev.med.56.062904.144915
43. Ponomarenko JV, Orlova GV, Frolov AS, Gelfand MS, Ponomarenko MP (2002) SELEX_DB: a database on in vitro selected oligomers adapted for recognizing natural sites and for analyzing both SNPs and site-directed mutagenesis data. Nucleic Acids Res 30:195–199
44. Price WN 2nd et al (2009) Understanding the physical properties that control protein crystallization by analysis of large-scale experimental data. Nat Biotechnol 27:51–57. doi:10.1038/nbt.1514
45. Robertson DL, Joyce GF (1990) Selection in vitro of an RNA enzyme that specifically cleaves single-stranded DNA. Nature 344:467–468. doi:10.1038/344467a0
46. Sabeti PC, Unrau PJ, Bartel DP (1997) Accessing rare activities from random RNA sequences: the importance of the length of molecules in the starting pool. Chem Biol 4:767–774. doi:10.1016/S1074-5521(97)90315-X
47. Sefah K, Shangguan D, Xiong X, O’Donoghue MB, Tan W (2010) Development of DNA aptamers using Cell-SELEX. Nat Protoc 5:1169–1185. doi:10.1038/nprot.2010.66
48. Serganov A, Patel DJ (2007) Ribozymes, riboswitches and beyond: regulation of gene expression without proteins. Nat Rev Genet 8:776–790. doi:10.1038/nrg2172
49. Silverman SK (2009) Artificial functional nucleic acids: aptamers ribozymes, and deoxyribozymes identified by in vitro selection. Funct Nucleic Acids Anal Appl 1:47–108. doi:10.1007/978-0-387-73711-9_3
50. Stoltenburg R, Reinemann C, Strehlitz B (2005) FluMag-SELEX as an advantageous method for DNA aptamer selection. Anal Bioanal Chem 383:83–91. doi:10.1007/s00216-005-3388-9
51. Thodima V, Pirooznia M, Deng Y (2006) RiboaptDB: a comprehensive database of ribozymes and aptamers. BMC Bioinform 7(Suppl 2):S6. doi:10.1186/1471-2105-7-S2-S6
52. Tolle F, Brandle GM, Matzner D, Mayer G (2015) A versatile approach towards nucleobase-modified aptamers. Angew Chem. doi:10.1002/anie.201503652
53. Tuerk C, Gold L (1990) Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249:505–510
54. Velez TE et al (2012) Systematic evaluation of the dependence of deoxyribozyme catalysis on random region length. ACS Comb Sci 14:680–687. doi:10.1021/co300111f
55. Waldrop MM (1989) Did life really start out in an RNA world? Science 246:1248–1249
56. Walsh R, DeRosa MC (2009) Retention of function in the DNA homolog of the RNA dopamine aptamer. Biochem Biophys Res Commun 388:732–735. doi:10.1016/j.bbrc.2009.08.084
57. Zhu G, Ye M, Donovan MJ, Song E, Zhao Z, Tan W (2012) Nucleic acid aptamers: an emerging frontier in cancer therapy. Chem Commun 48:10472–10480. doi:10.1039/c2cc35042d